Stay updated on Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial
Sign up to get notified when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.

Latest updates to the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page; this appears to be a maintenance/versioning update with no changes to study content.SummaryDifference0.0%

- Check14 days agoChange DetectedFooter now displays Revision: v3.4.3 instead of Revision: v3.4.2.SummaryDifference0.0%

- Check21 days agoChange DetectedThe Blood 2024 publication citation Friedberg et al. was added and subsequently removed from the Publications section.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedFooter now shows Revision: v3.4.2, replacing the previous Revision: v3.4.1. The notice about lapse in government funding was removed.SummaryDifference0.3%

- Check49 days agoChange DetectedAdded a government funding lapse notice and updated the publications section with a 2024 Blood article citation; the page revision was updated to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check56 days agoChange DetectedAdds a glossary display option and updates QC metadata to Revision: v3.4.0, while removing older QC wording. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.